Share
Osteoarthritis Market Size, Share, and Analysis, By Type (Hip Osteoarthritis, Knee Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis, Spinal Osteoarthritis), By Drug Type (Analgesics, Corticosteroids, Viscosupplementation agents, Nonsteroidal anti-inflammatory drugs {NSAIDS}), By Diagnosis (Imagining and Joint Fluid Analysis), By Route of Administration (Parenteral Route, Oral Route, Topical Route), By Treatment (Medication, Therapy, Surgery), By Distribution Channel (Hospitals Pharmacy, E-Commerce, Retail Pharmacy, Drug Store), By Purchasing Pattern (Prescription Drugs, Over-The-Counter Drugs) and Regional Forecasts, 2022-2032
The global Osteoarthritis market size was USD 5.85 billion in 2021 and projected to grow from USD 6.9 billion in 2023 to USD 15 billion by 2032, exhibiting a CAGR of 9.0% during the forecast period
Osteoarthritis (OA) is a common condition which affects the shoulders, fingers, knees, feet, back, hips, and neck joints. The progressive deterioration of the joint cartilage is its characteristic. OA can be identified through X-ray, medical assessment, lab tests, arthroscopic, joint fluid analysis, and magnetic resonance imaging (MRI) scans. Several surgical methods & drugs are preferred to treat the indications and symptoms. Few symptoms of OA are stiffness, discomfort, oedema, lack of flexibility, chronic pain, bone spurs, and sleep disruptions. The poor dietary habits, sedentary lifestyle, increased obesity and blood sugar levels are a major reason for acquiring OA.
Osteoarthritis Market is expected to project a CAGR of 9.0% during forecast period, 2022-2032
Osteoarthritis market is expected to reach USD 15 billion at a CAGR of 9.0% during forecast period owing to the increasing awareness about Osteoarthritis and the accessibility to advanced treatments are boosting the growth of osteoarthritis treatment. The increasing demand for minimal invasive non-surgical treatments assist in the growth of the osteoarthritis market.
Spinal Osteoarthritis segment is expected to dominate during the forecast period
Osteoarthritis Market is classified based on the Type into Hip Osteoarthritis, Knee Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis, Spinal Osteoarthritis. Spinal Osteoarthritis segment is expected to dominate market during the forecast period owing to the increasing acquirance of sedentary lifestyles, rising obesity rates which is expected to drive the spinal osteoarthritis market growth. The rising preference of minimal invasive procedures of surgery and the advancements of new treatments are aiding in the growth of the market.
Imagining segment is expected to dominate during the forecast period
Osteoarthritis Market is classified based on the Diagnosis into Imagining and Joint Fluid Analysis. Imagining segment is expected to dominate the market in the forecast period as the Imaging technologies play a vital role in diagnosis and management of osteoarthritis. Imagining includes Radiography which is used commonly in osteoarthritis research and clinical management, which helps in screening procedures and is expected to boost the growth of the segment in the Osteoarthritis Market.
Market Dynamics: Growing Demand for Osteoarthritis Products is Expected to Drive Market Growth
There is an increase in the growth of geriatric population and therefore, the incidence of osteoarthritis is responsible to the growth of the market. The awareness about benefits of non-invasive treatments and effective pain management products is increasing and the access to products with advanced technologies are expected to boost the growth of osteoarthritis market. The novel treatment developments and rising investments in research and development are driving the market growth.
Expansion of New Therapies is Expected to Boost the Market Growth
Several new developments like targeted therapies have evolved such as small molecule inhibitors and the utilization of biomarkers for diagnosis purpose is expected to boost the growth of osteoarthritis market. Few treatment plans are tailored based on the requirement of an individual biology and medication can be planned accordingly to optimize the advantages of therapy & reduce adverse effects. The sedentary lifestyle contributes to the market growth.
Restraint
Incidence of Cardiovascular Diseases May Restrain the Market Growth
There is an increased chance in occurrence of cardiovascular diseases due to the administration of nonsteroidal anti-inflammatory drugs to treat osteoarthritis which may restrain the growth of Osteoarthritis market.
Recent Developments:
Key Players Covered:
Osteoarthritis Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America region dominated the Osteoarthritis Market in 2021 and is also expected to dominate over the forecast period owing to the increasing awareness on osteoarthritis and the growing investments in research and development field by pharma companies which is assisting to the osteoarthritis market growth in this region. The acquisition of modern technologies of medicine and the presence of major market players are expected to drive the growth of the market. The pipeline development of OA market is strong with new developments which is further expected to boost the growth of the market.
The COVID-19 outbreak had resulted in the economic downfall. Several countries had imposed lockdowns and travel bans to control coronavirus spread. Covid-19 has affected several industries and even led to shutdown of many business activities. Covid-19 pandemic had a minor impact on the growth of osteoarthritis market.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2032 |
|
Base Year |
2022 |
|
Forecast Period |
2022-2032 |
|
Historical Period |
2019-2021 |
|
Growth Rate |
CAGR of 9.0% from 2022-2032 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
Type |
|
|
Drug Type |
|
|
Diagnosis |
|
|
Route of Administration |
|
|
Treatment |
|
|
Distribution Channel |
|
|
Purchasing Pattern |
|
|
By Region |
|
Osteoarthritis Market size was estimated at USD 5.85 billion in 2021 and is expected to reach USD 15 billion in 2032.
Osteoarthritis (OA) is a common condition which affects the shoulders, fingers, knees, feet, back, hips, and neck joints. The progressive deterioration of the joint cartilage is its characteristic. OA can be identified through X-ray, medical assessment, lab tests, arthroscopic, joint fluid analysis, and magnetic resonance imaging (MRI) scans.
Spinal Osteoarthritis and Imaging segment accounted for the largest Osteoarthritis market share.
Key players: Pfizer Inc., Abbott, Novartis AG, Eli Lilly and Company., Bayer AG, Johnson & Johnson, ABIOGEN PHARMA S.p.A, Merck Sharp & Dohme Corp., Apotex Inc., TissueGene Inc., Ampio Pharmaceuticals Inc., Mylan N.V., Tolmar Pharmaceuticals, Inc and Other Prominent Players are the key players in the Osteoarthritis Market.
Growing Demand for Osteoarthritis Products and Expansion of New Therapies are the factors driving the Osteoarthritis market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
